284 related articles for article (PubMed ID: 30999915)
1. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
[TBL] [Abstract][Full Text] [Related]
2. New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
Krudsood S; Looareesuwan S; Tangpukdee N; Wilairatana P; Phumratanaprapin W; Leowattana W; Chalermrut K; Ramanathan S; Navaratnam V; Olliaro P; Vaillant M; Kiechel JR; Taylor WR
Antimicrob Agents Chemother; 2010 Sep; 54(9):3730-7. PubMed ID: 20547795
[TBL] [Abstract][Full Text] [Related]
3. An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
Valecha N; Phyo AP; Mayxay M; Newton PN; Krudsood S; Keomany S; Khanthavong M; Pongvongsa T; Ruangveerayuth R; Uthaisil C; Ubben D; Duparc S; Bacchieri A; Corsi M; Rao BH; Bhattacharya PC; Dubhashi N; Ghosh SK; Dev V; Kumar A; Pukrittayakamee S
PLoS One; 2010 Jul; 5(7):e11880. PubMed ID: 20689583
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border.
Hoglund RM; Ruengweerayut R; Na-Bangchang K
Malar J; 2018 Sep; 17(1):322. PubMed ID: 30176888
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon.
Ramharter M; Kurth FM; Bélard S; Bouyou-Akotet MK; Mamfoumbi MM; Agnandji ST; Missinou MA; Adegnika AA; Issifou S; Cambon N; Heidecker JL; Kombila M; Kremsner PG
J Antimicrob Chemother; 2007 Nov; 60(5):1091-6. PubMed ID: 17884832
[TBL] [Abstract][Full Text] [Related]
6. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
Gutman J; Green M; Durand S; Rojas OV; Ganguly B; Quezada WM; Utz GC; Slutsker L; Ruebush TK; Bacon DJ
Malar J; 2009 Apr; 8():58. PubMed ID: 19358697
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.
Leang R; Ros S; Duong S; Navaratnam V; Lim P; Ariey F; Kiechel JR; Ménard D; Taylor WR
Malar J; 2013 Sep; 12():343. PubMed ID: 24060207
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria.
Jullien V; Valecha N; Srivastava B; Sharma B; Kiechel JR
Malar J; 2014 May; 13():187. PubMed ID: 24886117
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
Lek D; Rachmat A; Harrison D; Chin G; Chaoratanakawee S; Saunders D; Menard D; Rogers WO
Malar J; 2022 Sep; 21(1):259. PubMed ID: 36071520
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of artesunate and amodiaquine in African children.
Stepniewska K; Taylor W; Sirima SB; Ouedraogo EB; Ouedraogo A; Gansané A; Simpson JA; Morgan CC; White NJ; Kiechel JR
Malar J; 2009 Aug; 8():200. PubMed ID: 19691851
[TBL] [Abstract][Full Text] [Related]
11. Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities.
Santelli AC; Ribeiro I; Daher A; Boulos M; Marchesini PB; dos Santos RL; Lucena MB; Magalhães I; Leon AP; Junger W; Ladislau JL
Malar J; 2012 Aug; 11():286. PubMed ID: 22905900
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of mefloquine with dihydroartemisinin as 2-day regimens in patients with uncomplicated falciparum malaria.
Thuy le TD; Hung le N; Hung NC; Na-Bangchang K
Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):205-12. PubMed ID: 17539268
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.
Li Q; Remich S; Miller SR; Ogutu B; Otieno W; Melendez V; Teja-Isavadharm P; Weina PJ; Hickman MR; Smith B; Polhemus M
Malar J; 2014 Jul; 13():281. PubMed ID: 25047305
[TBL] [Abstract][Full Text] [Related]
14. Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria.
Saeheng T; Na-Bangchang K
PLoS One; 2023; 18(2):e0282099. PubMed ID: 36821622
[TBL] [Abstract][Full Text] [Related]
15. Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
Dini S; Zaloumis S; Cao P; Price RN; Fowkes FJI; van der Pluijm RW; McCaw JM; Simpson JA
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150462
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria.
Reuter SE; Upton RN; Evans AM; Navaratnam V; Olliaro PL
J Antimicrob Chemother; 2015 Mar; 70(3):868-76. PubMed ID: 25377567
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
Lee SJ; Ter Kuile FO; Price RN; Luxemburger C; Nosten F
PLoS One; 2017; 12(2):e0168780. PubMed ID: 28192434
[TBL] [Abstract][Full Text] [Related]
19. Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India.
Valecha N; Srivastava B; Dubhashi NG; Rao BH; Kumar A; Ghosh SK; Singh JP; Kiechel JR; Sharma B; Jullien V; Dash AP; Taylor WR; Anvikar AR
J Vector Borne Dis; 2013 Dec; 50(4):258-64. PubMed ID: 24499847
[TBL] [Abstract][Full Text] [Related]
20. Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate.
Na-Bangchang K; Ruengweerayut R; Wernsdorfer WH
Eur J Clin Pharmacol; 2011 Jul; 67(7):687-91. PubMed ID: 21556929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
